Neuphoria Therapeutics
NEUP
#10123
Rank
S$29.77 M
Marketcap
S$5.54
Share price
0.00%
Change (1 day)
14.67%
Change (1 year)

Neuphoria Therapeutics (NEUP) - Cash on Hand

Cash on Hand as of March 2025 : S$22.09 Million

According to Neuphoria Therapeutics's latest financial reports the company has S$22.09 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neuphoria Therapeutics - Cash on Hand chart (from 2022 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30S$17.08 M56.62%
2023-06-30S$10.9 M-66.02%
2022-06-30S$32.09 M48.68%
2021-06-30S$21.58 M613.52%
2020-06-30S$3.02 M-68.69%
2019-06-30S$9.66 M-48.82%
2018-06-30S$18.88 M-46.45%
2017-06-30S$35.26 M2.31%
2016-06-30S$34.47 M59.92%
2015-06-30S$21.55 M85.47%
2014-06-30S$11.62 M-51.04%
2013-06-30S$23.73 M3.09%
2012-06-30S$23.02 M2.04%
2011-06-30S$22.56 M78.99%
2010-06-30S$12.6 M181%
2009-06-30S$4.48 M-42.63%
2008-06-30S$7.82 M-44.63%
2007-06-30S$14.12 M241.94%
2006-06-30S$4.13 M-53.44%
2005-06-30S$8.87 M23.14%
2004-06-30S$7.2 M50.2%
2003-06-30S$4.79 M-0.07%
2002-06-30S$4.79 M710535.88%
2001-06-30S$0 M-99.79%
2000-06-30S$0.32 M401.94%
1999-06-30S$0.06 M